Diana Rodríguez

Diana Rodríguez

Auto-generated profile, based on publicly available information

Diana Rodríguez

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, Jenaro de la Fuente s/n, 15782 Santiago de Compostela, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Concepción González-BelloConcepción González-Bello
Concepción González-Bello
DRDiana Rodríguez
Diana Rodríguez
MPMarina Pernas
Marina Pernas
ÁRÁngela Rodríguez
Ángela Rodríguez
ECEsther Colchón
Esther Colchón

20 March 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DRDiana Rodríguez
Diana Rodríguez
MMMaría Maneiro
María Maneiro
Juan Carlos Vázquez-UchaJuan Carlos Vázquez-Ucha
Juan Carlos Vázquez-Ucha
ABAlejandro Beceiro
Alejandro Beceiro
Concepción González-BelloConcepción González-Bello
Concepción González-Bello

20 March 2020 in Peptide Science
Verified
Journal Article
Open access
PDF file
ALAyanna Lindsey‐Crosthwait
Ayanna Lindsey‐Crosthwait
DRDiana Rodriguez‐Lema
Diana Rodriguez‐Lema
MWMartin Walko
Martin Walko
CPChristopher M. Pask
Christopher M. Pask
AWAndrew J. Wilson
Andrew J. Wilson
Methods to constrain peptides in a bioactive α‐helical conformation for inhibition of protein‐protein interactions represent an ongoing area of investigation in chemical biology. Recently, the first example of a reversible “stapling” methodology was described which exploits native cysteine or homocysteine residues spaced at the i and i + 4 positions in a peptide sequence together with the thiol selective reactivity of dibromomaleimides (a previous study). This manuscript reports on the optimization of the maleimide based constraint, focusing on the kinetics of macrocyclization and the extent to which helicity is promoted with different thiol containing amino acids. The study identified an optimal stapling combination of X1 = L‐Cys and X5 = L‐hCys in the context of the model peptide Ac‐X1AAAX5‐NH2, which should prove useful in implementing the dibromomaleimide stapling strategy in peptidomimetic ligand discovery programmes.

14 May 2026 in ChemMedChem
Verified
Journal Article
Open access
DRDiana Rodríguez
Diana Rodríguez
ELEmilio Lence
Emilio Lence
Juan Carlos Vázquez-UchaJuan Carlos Vázquez-Ucha
Juan Carlos Vázquez-Ucha
ABAlejandro Beceiro
Alejandro Beceiro
Concepción González-BelloConcepción González-Bello
Concepción González-Bello
β‐Lactam antibiotics, which account for nearly 70% of all prescriptions for bacterial infections, remain the cornerstone of antimicrobial chemotherapy. However, their clinical effectiveness is increasingly compromised by the widespread emergence of β‐lactamase‐mediated resistance. These enzymes hydrolyze the β‐lactam ring through an addition–elimination mechanism, abolishing antibacterial activity. Preserving the efficacy of β‐lactam antibiotics, particularly carbapenems, regarded as the last line of defense against multidrug‐resistant (MDR) pathogens, is therefore critical. Here, we report the design and synthesis of compound 3 , a zwitterionic penicillin‐derived sulfone that integrates two key principles: enhanced permeability of zwitterionic molecules and improved inhibitory potency through (2‐pyridyl)methylene introduction within the sulbactam scaffold to achieve an adduct stable against hydrolysis. In vitro assays demonstrated that compound 3 significantly restored β‐lactam activity against MDR pathogens producing extended‐spectrum β‐lactamases (ESBLs) and carbapenem‐hydrolyzing class D β‐lactamases. It notably improved imipenem and ceftazidime efficacy against strains expressing OXA‐48 and PDC‐1, whose inhibitory capacity was determined by kinetic analysis with the isolated enzymes. Mechanistic studies using mass spectrometry and molecular dynamics simulations revealed ligand‐induced pocket formation, π‐stacking modulation, and hydrophobic engagement, supporting a covalent, water‐shielded inactivation pathway via indolizine adduct formation. The nonsterically hindered amine in 3 favored PDC‐1 binding and overall permeability while exerting a neutral effect on OXA‐48 binding. These results underscore the potential of compound 3 as a next‐generation β‐lactamase inhibitor for combating infections caused by ESBL‐ and carbapenemase‐producing Enterobacterales and Pseudomonas aeruginosa .